Clicky

Moderna Inc(0QF)

Description: Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


Keywords: Biotechnology Cancer Infectious Diseases Vaccines Rare Diseases Cardiovascular Disease Herpes Simplex Virus Treatment Of Infectious Diseases Auto Immune Diseases Biomedical Advanced Research And Development Authority Human Orthopneumovirus Personalized Cancer Melinda Gates Foundation Defense Advanced Research Projects Agency

Home Page: www.modernatx.com

200 Technology Square
Cambridge, MA 02139
United States
Phone: 617 714 6500


Officers

Name Title
Dr. Noubar B. Afeyan Ph.D. Co-Founder, Independent Non Exec. Chairman & Member of Technology Advisory Board
Mr. Stephane Bancel CEO & Director
Dr. Stephen Hoge M.D. Pres
Ms. Shannon Thyme Klinger Chief Legal Officer & Corp. Sec.
Mr. Juan Andres Pres of Strategic Partnerships & Enterprise Expansion
Mr. James M. Mock Chief Financial Officer
Dr. Jerh Collins Ph.D. Chief Technical Operations & Quality Officer
Dr. John V. W. Reynders Ph.D. Chief Information Officer
Dr. Melissa J. Moore Ph.D. Chief Scientific Officer & Member of Scientific Advisory Board
Ms. Lavina Talukdar CFA Sr. VP & Head of Investor Relations

Exchange: F

Country: DE

Currency: Euro (€)

Forward PE: 32.4675
Trailing PE: 6.474
Price-to-Book MRQ: 4.4562
Price-to-Sales TTM: 3.479
IPO Date:
Fiscal Year End: December
Full Time Employees: 3700
Back to stocks